Year: 2014

At the end of the study, none of the IPE group experienced significant weight gain, and had less abdominal and liver fat than the dietary fiber group.
Go to Source

LONDON (Reuters) – The Red Cross warned on Thursday of a possible rise in the rate of Ebola infections in West Africa as people travel across the region during the festive holidays. Urging people to take extra care to limit the spread of the virus, International Federation of the Red Cross and Red Crescent Societies (IFRC) Secretary General Elhadj As Sy said increasing rates were not inevitable but a real risk. "Now is the time to be even more vigilant," he told an audience at the Royal Institute of International Affairs in London. …

Go to Source

By Ben Hirschler LONDON (Reuters) – GAVI, the global vaccines alliance, said on Thursday it was committing up to $300 million to buy Ebola vaccines and was ready to begin procurement as soon as the World Health Organization recommends one for use. As much as $90 million more could also be made available to help affected countries introduce the vaccines and to rebuild their health systems, it added. …
Go to Source

By Ben Hirschler and Kate Kelland LONDON (Reuters) – Scientists racing to develop vaccines against Ebola are trying to determine whether they can best fight the disease with a single injection or with two, a calculation that could determine how quickly and effectively a program can be rolled out. Administering two vaccines, one after the other, would almost certainly give far greater protection than a single shot against a deadly virus that has killed more than 6,000 people in West Africa this year. …

Go to Source

GENEVA (Reuters) – A clinical trial of an Ebola vaccine developed by Merck and NewLink has been halted temporarily as a precautionary measure after four patients complained of joint pains, the University of Geneva Hospital said on Thursday. “They are all fine and being monitored regularly by the medical team leading the study,” it said in a statement. The human safety trials, which began in Geneva on Nov. 10, are due to resume on Jan. 5 in up to 15 volunteers after checks to ensure that joint pain symptoms in hands and feet were “benign and temporary”, the hospital said. …
Go to Source

LONDON (AP) — Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects.
Go to Source